Skip to main content
NCBI home page
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2008;2008:353–364. doi: 10.1007/978-3-540-77290-3_33

Management of Ventilator-associated Pneumonia

M Ferrer 3, M Valencia 4, A Torres 4
PMCID: PMC7123849

Abstract

Pneumonia is the most important respiratory infection in mechanically ventilated patients. It is defined as the presence of microorganisms in the pulmonary parenchyma leading to the development of an inflammatory response by the host, which may be localized in the lung or may extend systemically. Nosocomial pneumonia is an infectious process which develops within 48 hours after admission to the hospital and that was not incubating at the time of hospitalization. Ventilator-associated pneumonia (VAP) is considered as a subgroup of nosocomial pneumonia and is an infectious pulmonary process which develops 48 hours after the presence of an artificial airway and mechanical ventilation. Since a large proportion of the patients who develop nosocomial pneumonia are intubated and receive mechanical ventilation, most epidemiological and clinical studies on nosocomial pneumonia have been focused on critically ill patients and those receiving mechanical ventilation. From a clinical point of view, nosocomial pneumonia is of great importance not only because of the consequences of the important morbidity and mortality but also due to the high costs associated with development of this disease.

Keywords: Mechanical Ventilation, Respir Crit, Nosocomial Pneumonia, Stress Ulcer Prophylaxis, Clinical Pulmonary Infection Score

References

  • 1.Langer M., Cigada M., Mandelli M., Mosconi P., Tognoni G. Early-onset pneumonia: a multicenter study in intensive care units. Intensive Care Med. 1987;13:342–346. doi: 10.1007/BF00255791. [DOI] [PubMed] [Google Scholar]
  • 2.Vincent J.L., Bihari D.J., Suter P.M., et al. The prevalence of nosocomial infection in intensive care units in Europe. JAMA. 1995;274:639–644. doi: 10.1001/jama.274.8.639. [DOI] [PubMed] [Google Scholar]
  • 3.Prodhom G., Leuenberger P., Koerfer J., et al. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. Ann Intern Med. 1994;120:653–662. doi: 10.7326/0003-4819-120-8-199404150-00005. [DOI] [PubMed] [Google Scholar]
  • 4.Torres A., Aznar R., Gatell J.M., et al. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis. 1990;142:523–528. doi: 10.1164/ajrccm/142.3.523. [DOI] [PubMed] [Google Scholar]
  • 5.Sopena N., Sabriá M., the Neunos Study group Multicenter study of hospital-acquired pneumonia in non-ICU patients. Chest. 2005;127:213–219. doi: 10.1378/chest.127.1.213. [DOI] [PubMed] [Google Scholar]
  • 6.Langer M., Mosconi P., Cigada M., Mandelli M. Long-term respiratory support and risk of pneumonia in critically ill patients. Am Rev Respir Dis. 1989;140:302–305. doi: 10.1164/ajrccm/140.2.302. [DOI] [PubMed] [Google Scholar]
  • 7.Fagon J.Y., Chastre J., Domart Y., et al. Nosocomial pneumonia in patients receiving continuous mechanical ventilation. Prospective analysis of 52 episodes with use of a protected specimen brush and quantitative culture techniques. Am Rev Respir Dis. 1989;139:877–884. doi: 10.1164/ajrccm/139.4.877. [DOI] [PubMed] [Google Scholar]
  • 8.Cook D.J., Walter S.D., Cook R.J., et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med. 1998;129:433–440. doi: 10.7326/0003-4819-129-6-199809150-00002. [DOI] [PubMed] [Google Scholar]
  • 9.Craven D.E., Kunches L.M., Kilinsky V., Lichtenberg D.A., Make B.J., McCabe W.R. Risk factors for pneumonia and fatality in patients receiving mechanical ventilation. Am Rev Respir Dis. 1986;133:792–796. [PubMed] [Google Scholar]
  • 10.Kollef M.H. Ventilator-associated pneumonia: A multivariate analysis. JAMA. 1993;270:1965–1970. doi: 10.1001/jama.270.16.1965. [DOI] [PubMed] [Google Scholar]
  • 11.Lossos I.S., Breuer R., Or R., et al. Bacterial pneumonia in recipients of bone marrow transplantation. A five-year prospective study. Transplantation. 1995;60:672–678. doi: 10.1097/00007890-199510150-00010. [DOI] [PubMed] [Google Scholar]
  • 12.Antonelli M., Moro M.L., Capelli O., et al. Risk factors for early-onset pneumonia in trauma patients. Chest. 1994;105:224–228. doi: 10.1378/chest.105.1.224. [DOI] [PubMed] [Google Scholar]
  • 13.Cardeñosa Cendrero J.A., Sole-Violan J., Bordes Benitez A., et al. Role of different routes of tracheal colonization in the development of pneumonia in patients receiving mechanical ventilation. Chest. 1999;116:462–470. doi: 10.1378/chest.116.2.462. [DOI] [PubMed] [Google Scholar]
  • 14.Johanson W.G., Pierce A.K., Sanford J.P., Thomas G.D. Nosocomial respiratory infection with Gram-negative bacilli: the significance of colonization of the respiratory tract. Ann Intern Med. 1972;77:701–706. doi: 10.7326/0003-4819-77-5-701. [DOI] [PubMed] [Google Scholar]
  • 15.Estes R.J., Meduri G.U. The pathogenesis of ventilator-associated pneumonia: I. Mechanisms of bacterial transcolonization and airway inoculation. Intensive Care Med. 1995;21:365–383. doi: 10.1007/BF01705418. [DOI] [PubMed] [Google Scholar]
  • 16.Garrouste-Orgeas M., Chevret S., Arlet G., et al. Oropharyngeal or gastric colonization and nosocomial pneumonia in adult intensive care unit patients. A prospective study based on genomic DNA analysis. Am J Respir Crit Care Med. 1997;156:1647–1655. doi: 10.1164/ajrccm.156.5.96-04076. [DOI] [PubMed] [Google Scholar]
  • 17.Rello J., Sonora R., Jubert P., Artigas A., Rue M., Valles J. Pneumonia in intubated patients: Role of respiratory airway care. Am J Respir Crit Care Med. 1996;154:111–115. doi: 10.1164/ajrccm.154.1.8680665. [DOI] [PubMed] [Google Scholar]
  • 18.Sirvent J.M., Torres A., El-Ebiary M., Castro P., de Batlle J., Bonet A. Protective effect of intravenously administered cefuroxime against nosocomial pneumonia in patients with structural coma. Am J Respir Crit Care Med. 1997;155:1729–1734. doi: 10.1164/ajrccm.155.5.9154884. [DOI] [PubMed] [Google Scholar]
  • 19.Rello J., Ausina V., Ricart M., Castella J., Prats G. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest. 1993;104:1230–1235. doi: 10.1378/chest.104.4.1230. [DOI] [PubMed] [Google Scholar]
  • 20.Trouillet J.L., Chastre J., Vuagnat A., et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am Rev Respir Dis. 1998;157:531–539. doi: 10.1164/ajrccm.157.2.9705064. [DOI] [PubMed] [Google Scholar]
  • 21.Torres A., Serra-Batlles J., Ros E., et al. Pulmonary aspiration of gastric contents in patients receiving mechanical ventilation: the effect of body position. Ann Intern Med. 1992;116:540–543. doi: 10.7326/0003-4819-116-7-540. [DOI] [PubMed] [Google Scholar]
  • 22.Orozco-Levi M., Torres A., Ferrer M., et al. Semirecumbent position protects from pulmonary aspiration but not completely from gastroesophageal reflux in mechanically ventilated patients. Am J Respir Crit Care Med. 1995;152:1387–1390. doi: 10.1164/ajrccm.152.4.7551400. [DOI] [PubMed] [Google Scholar]
  • 23.Drakulovic M.B., Torres A., Bauer T.T., Nicolas J.M., Nogue S., Ferrer M. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Lancet. 1999;354:1851–1858. doi: 10.1016/S0140-6736(98)12251-1. [DOI] [PubMed] [Google Scholar]
  • 24.Tryba M. Risk of acute stress bleeding and nosocomial pneumonia in ventilated intensive care patients: Sucralfate versus antacids. Am J Med. 1987;83:117–124. doi: 10.1016/0002-9343(87)90840-0. [DOI] [PubMed] [Google Scholar]
  • 25.Cook D., Guyatt G., Marshall J., et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med. 1998;338:791–797. doi: 10.1056/NEJM199803193381203. [DOI] [PubMed] [Google Scholar]
  • 26.Messori A., Tripoli S., Vaiani M., et al. Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: meta-analysis of randomised controlled trials. BMJ. 2003;32:1103–1106. doi: 10.1136/bmj.321.7269.1103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Fabregas N., Ewig S., Torres A., et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax. 1999;54:867–873. doi: 10.1136/thx.54.10.867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Pugin J., Auckenthaler R., Mili N., Janssens J.P., Lew P.D., Suter P. Diagnosis of ventilator associated pneumonia by bacteriologic analysis of bronchoscopic and non-bronchoscopic “blind” bronchoalveolar lavage fluid. Am Rev Respir Dis. 1991;143:1121–112. doi: 10.1164/ajrccm/143.5_Pt_1.1121. [DOI] [PubMed] [Google Scholar]
  • 29.Fartoukh M., Maitre B., Honore S., et al. Diagnosing pneumonia during mechanical ventilation: The clinical pulmonary infection score revisited. Am J Respir Crit Care Med. 2003;168:173–179. doi: 10.1164/rccm.200212-1449OC. [DOI] [PubMed] [Google Scholar]
  • 30.Ioanas M., Ferrer M., Angrill J., Ferrer M., Torres A. Microbial investigation on vetilator-associated pneumonia. Eur Respir J. 2001;17:791–801. doi: 10.1183/09031936.01.17407910. [DOI] [PubMed] [Google Scholar]
  • 31.Valencia M., Torres A., Insausti J., et al. Valor diagnóstico del cultivo cuantitativo del aspirado endotraqueal en la neumonía adquirida durante la ventilación mecánica. Estudio multicéntrico. Arch Bronconeumol. 2003;39:394. doi: 10.1157/13050628. [DOI] [PubMed] [Google Scholar]
  • 32.Torres A., Puig de la Bellacasa J., Xaubet A., et al. Diagnostic value of quantitative cultures of bronchoalveolar lavage and telescoping plugged catheters in mechanically ventilated patients with bacterial pneumonia. Am Rev Respir Dis. 1989;140:306–310. doi: 10.1164/ajrccm/140.2.306. [DOI] [PubMed] [Google Scholar]
  • 33.Sanchez-Nieto J.M., Torres A., Garcia-Cordoba F., et al. Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia: a pilot study. Am J Respir Crit Care Med. 1998;157:371–376. doi: 10.1164/ajrccm.157.2.97-02039. [DOI] [PubMed] [Google Scholar]
  • 34.Sole-Violan J., Fernandez J.A., Benitez A.B., Cardenosa Cendrero J.A., Rodriguez de Castro F. Impact of quantitative invasive diagnostic techniques in the management of outcome of mechanically ventilated patients with suspected pneumonia. Crit Care Med. 2000;28:2737–2741. doi: 10.1097/00003246-200008000-00009. [DOI] [PubMed] [Google Scholar]
  • 35.Ruiz M., Torres A., Ewig S., et al. Noninvasive versus invasive microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med. 2000;162:119–125. doi: 10.1164/ajrccm.162.1.9907090. [DOI] [PubMed] [Google Scholar]
  • 36.Fagon J.Y., Chastre J., Wolff M., et al. Invasive and noninvasive strategies for management of suspected ventilator-associated pneumonia. Ann Intern Med. 2000;132:621–630. doi: 10.7326/0003-4819-132-8-200004180-00004. [DOI] [PubMed] [Google Scholar]
  • 37.Torres A., Ewig S. Diagnosing ventilator-associated pneumonia. N Engl J Med. 2004;350:433–435. doi: 10.1056/NEJMp038219. [DOI] [PubMed] [Google Scholar]
  • 38.Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. Intensive Care Med. 1996;22:387–94. doi: 10.1007/BF01712153. [DOI] [PubMed] [Google Scholar]
  • 39.Luna C.M., Vujacich P., Niederman M.S., et al. Impact of BAL data on therapy and outcome of ventilator-associated pneumonia. Chest. 1997;111:676–687. doi: 10.1378/chest.111.3.676. [DOI] [PubMed] [Google Scholar]
  • 40.Rello J., Diaz E. Pneumonia in the intensive care unit. Crit Care Med. 2003;31:2544–2551. doi: 10.1097/01.CCM.0000089928.84326.D2. [DOI] [PubMed] [Google Scholar]
  • 41.Kollef M.H., Ward S. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest. 1998;113:412–420. doi: 10.1378/chest.113.2.412. [DOI] [PubMed] [Google Scholar]
  • 42.Rello J., Gallego M., Mariscal D., Sonora R., Valles J. The value of routine microbiologic investigation in the diagnosis of ventilator-associated pneumonia. Am J Respir Crit Care Med. 1997;156:196–200. doi: 10.1164/ajrccm.156.1.9607030. [DOI] [PubMed] [Google Scholar]
  • 43.American Thoracic Society Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies. A consensus statement. Am J Respir Crit Care Med. 1996;153:1711–1725. doi: 10.1164/ajrccm.153.5.8630626. [DOI] [PubMed] [Google Scholar]
  • 44.Ioanas M., Cavalcanti M., Ferrer M., et al. Hospital-acquired pneumonia: coverage and treatment adequacy of current guidelines. Eur Respir J. 2003;22:876–882. doi: 10.1183/09031936.03.00045903. [DOI] [PubMed] [Google Scholar]
  • 45.Niederman M., Craven D. Guidelines for the management of adults with hospital-acquired pneumonia, ventilator-associated pneumonia, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388–416. doi: 10.1164/rccm.200405-644ST. [DOI] [PubMed] [Google Scholar]
  • 46.Hilf M., Yu V.L., Sharp J., Zuravleff J.J., Korvick J.A., Muder R.R. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med. 1989;87:540–546. doi: 10.1016/S0002-9343(89)80611-4. [DOI] [PubMed] [Google Scholar]
  • 47.Korvick J.A., Bryan C.S., Farber B., et al. Prospective observational study of Klebsiella bacteremia in 230 patients: outcome for antibiotic combinations versus monotherapy. Antimicrob Agents Chemother. 1992;36:2639–2644. doi: 10.1128/aac.36.12.2639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Chastre J., Wolff M., Fagon J.Y., et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003;290:2588–2598. doi: 10.1001/jama.290.19.2588. [DOI] [PubMed] [Google Scholar]

Articles from Yearbook of Intensive Care and Emergency Medicine are provided here courtesy of Nature Publishing Group

RESOURCES